Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex respiratory diseases.

Otolaryngology, Pneumology, Video

During the 8th annual Microbiome Movement Drug Development Europe, held in Barcelona (Spain), Microbiomepost sat down with Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, to discuss the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex respiratory diseases.

Most recent

Oncology

HCPs Area

World Microbiome Day 2023: Microbes and Food

Probiotics for female indications: Impact of Probi® probiotics for bone health support

Industry

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

Read more about LBP

Oncology

Engineering Live biotherapeutics to treat complex respiratory diseases

Most recent

Gut bacteria may improve response to immunotherapy in people with melanoma

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

New AI model predicts gut microbial load, revealing its role in health and disease

HCPs Area

World Microbiome Day 2023: Microbes and Food

Probiotics for female indications: Impact of Probi® probiotics for bone health support

Industry

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

Gut bacteria may improve response to immunotherapy in people with melanoma

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

New AI model predicts gut microbial load, revealing its role in health and disease

Tailored dietary strategies may boost remission for Crohn’s disease

Integrating microbiome data into food safety: EFSA’s approach to risk assessment in the agri-food chain

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

New virus-like agents identified in human gut and oral microbiotas